Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 25, 2022 11:45 ET | Source: The Law Offices of Frank R. Cruz

DEADLINE ALERT for SPRO, LMPX, MF, and YQ: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, July 25, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
July 21, 2022 12:50 ET | Source: The Rosen Law Firm PA

SPRO FINAL DEADLINE MONDAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Spero Therapeutics, Inc. Investors With Losses Over $100K to Secure Counsel Before Important July 25 Deadline in Securities Class Action – SPRO

NEW YORK, July 21, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spero Therapeutics, Inc. (NASDAQ: SPRO) between May 6,...
July 03, 2022 15:45 ET | Source: The Rosen Law Firm PA

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Spero Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SPRO

NEW YORK, July 03, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spero Therapeutics, Inc. (NASDAQ: SPRO) between October...
July 03, 2022 15:45 ET | Source: The Rosen Law Firm PA

全球備受信任和領先的律師事務所 ROSEN 鼓勵損失超過 10 萬美元的 Spero Therapeutics, Inc. 投資者在證券集體訴訟的重要截止日期前尋求法律意見 – SPRO

紐約, July 04, 2022 (GLOBE NEWSWIRE) -- 為何：全球投資者權益律師事務所 Rosen Law Firm 提醒在 2021 年 10 月 28 日至 2022 年 5 月 2 日（包括首尾兩天）期間（「集體訴訟期間」）購買 Spero Therapeutics, Inc. (NASDAQ: SPRO) 證券的購買者注意，2022 年 7 月 25...
June 23, 2022 01:15 ET | Source: The Rosen Law Firm PA

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – SPRO

NEW YORK, June 23, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spero Therapeutics, Inc. (NASDAQ: SPRO) between October...
June 18, 2022 20:00 ET | Source: The Rosen Law Firm PA

ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – SPRO

NEW YORK, June 18, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spero Therapeutics, Inc. (NASDAQ: SPRO) between October...
June 12, 2022 11:00 ET | Source: The Rosen Law Firm PA

ROSEN, A LEADING LAW FIRM, Encourages Spero Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – SPRO

NEW YORK, June 12, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Spero Therapeutics, Inc. (NASDAQ: SPRO) between October...
June 05, 2022 17:15 ET | Source: The Rosen Law Firm PA

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Spero Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – SPRO

NEW YORK, June 05, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Spero...
March 31, 2020 16:45 ET | Source: Spero Therapeutics, Inc.

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., March 31, 2020 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and...
March 16, 2020 08:45 ET | Source: Spero Therapeutics, Inc.

Spero Therapeutics Announces Fourth Quarter and Full-Year 2019 Operating Results and Provides Pipeline Update

CAMBRIDGE, Mass., March 16, 2020 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and...

Next Page keyboard_arrow_right